ID   SP-50B
AC   CVCL_C121
DR   Wikidata; Q54955387
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2548699;
RX   PubMed=8971032;
RX   PubMed=11061568;
CC   Population: Japanese.
CC   Virology: Contains an EBV genome in a circular episomal form.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D022 ! SP-49
OI   CVCL_M655 ! SP-52EB
OI   CVCL_C122 ! SP-53
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=2548699; DOI=10.1002/1097-0142(19890915)64:6<1248::AID-CNCR2820640614>3.0.CO;2-5;
RA   Daibata M., Kubonishi I., Eguchi T., Yano S., Ohtsuki Y., Miyoshi I.;
RT   "The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B)
RT   and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with
RT   t(11;14)(q13;q32) chromosome abnormality from an intermediate
RT   lymphocytic lymphoma.";
RL   Cancer 64:1248-1253(1989).
//
RX   PubMed=8971032; DOI=10.1128/JVI.70.12.9003-9007.1996; PMCID=PMC191000;
RA   Daibata M., Kubonishi I., Miyoshi I.;
RT   "Differential tumorigenicity between Epstein-Barr virus genome-positive
RT   and genome-negative cell lines with t(11;14)(q13;q32) derived from
RT   mantle cell lymphoma.";
RL   J. Virol. 70:9003-9007(1996).
//
RX   PubMed=11061568; DOI=10.18926/AMO/32293;
RA   Jin Z., Teramoto N., Yoshino T., Takada K., Oka T., Hayashi K.,
RA   Akagi T.;
RT   "Characterization of Epstein-Barr virus-infected mantle cell lymphoma
RT   lines.";
RL   Acta Med. Okayama 54:193-200(2000).
//